Back to Search
Start Over
Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences
Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences
- Source :
- Diabetes Spectr
- Publication Year :
- 2020
- Publisher :
- American Diabetes Association, 2020.
-
Abstract
- Many people with diabetes do not achieve individualized treatment targets. Therapeutic inertia, the underuse of effective therapies in preventing serious clinical end points, is a frequent, important contributor to this failure. Clinicians, patients, health systems, payors, and producers of medications, devices, and other products for those with diabetes all play a role in the development of therapeutic inertia and can all help to reduce it.
- Subjects :
- medicine.medical_specialty
business.industry
Endocrinology, Diabetes and Metabolism
MEDLINE
Individualized treatment
Diabetes prevalence
030209 endocrinology & metabolism
medicine.disease
03 medical and health sciences
0302 clinical medicine
Diabetes mellitus
From Research to Practice
Internal Medicine
medicine
030212 general & internal medicine
business
Intensive care medicine
Healthcare system
Therapeutic inertia
Subjects
Details
- ISSN :
- 19447353 and 10409165
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Diabetes Spectrum
- Accession number :
- edsair.doi.dedup.....309053bf08aac4c1f71de92c02875b71
- Full Text :
- https://doi.org/10.2337/ds19-0029